Goldy Medicos (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.45 M
- Company Age 28 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
- Revenue Growth %
- Profit Growth 39.59%
- Ebitda 56.52%
- Net Worth -3.43%
- Total Assets %
About Goldy Medicos (India)
Goldy Medicos (India) Private Limited (GMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 July 1996 and has a history of 28 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹1.50 M.
Rama Devi, Parveen Kumar, Goldy Tuteja, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233DL1996PTC080800
- Company No.
080800
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Goldy Medicos (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Goldy Tuteja  | Director | 01-Jan-2001 | Current |
| Rama Devi | Director | 31-Jul-1996 | Current |
| Parveen Kumar | Director | 31-Jul-1996 | Current |
| Umesh Sharma | Director | 31-Jul-1996 | Current |
Financial Performance of Goldy Medicos (India).
Goldy Medicos (India) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 39.59% increase in profit. The company's net worth dipped by a decrease of 3.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goldy Medicos (India)?
In 2017, Goldy Medicos (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mapar Bioceuticals Private LimitedParveen Kumar is a mutual person
- Vabros Gvmpl Private Limited
Goldy Tuteja is a mutual person
- Goldi & Vipul Medicare Private Limited
Goldy Tuteja is a mutual person
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Vijaya Bank : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2002 | Vijaya Bank | ₹1.50 M | Open |
How Many Employees Work at Goldy Medicos (India)?
Unlock and access historical data on people associated with Goldy Medicos (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goldy Medicos (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldy Medicos (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
